Addressing the opioid crisis, 3D printing drug guidelines, and execution drugs… What’s new for pharma in business?
The EMA and European Commission have published two documents containing guidance for pharma companies to help them prepare for Brexit. The documents answer queries covering the rights of market authorization holders, pharmacovigilance systems, manufacturing sites, recalls, studies, and more.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine